565 related articles for article (PubMed ID: 1646640)
1. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.
Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K
J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504
[TBL] [Abstract][Full Text] [Related]
3. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
Itin PH; Pittelkow MR; Kumar R
Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
5. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
6. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
Schwartz GG; Whitlatch LW; Chen TC; Lokeshwar BL; Holick MF
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):391-5. PubMed ID: 9610788
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
8. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25 dihydroxyvitamin D3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes.
Sebag M; Gulliver W; Kremer R
J Invest Dermatol; 1994 Sep; 103(3):323-9. PubMed ID: 8077697
[TBL] [Abstract][Full Text] [Related]
10. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
[TBL] [Abstract][Full Text] [Related]
11. 1,24(R)-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity.
Matsunaga T; Yamamoto M; Mimura H; Ohta T; Kiyoki M; Ohba T; Naruchi T; Hosoi J; Kuroki T
J Dermatol; 1990 Mar; 17(3):135-42. PubMed ID: 2162363
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation.
Pillai S; Bikle DD; Elias PM
J Biol Chem; 1988 Apr; 263(11):5390-5. PubMed ID: 2451669
[TBL] [Abstract][Full Text] [Related]
14. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression.
Dai X; Sayama K; Shirakata Y; Tokumaru S; Yang L; Tohyama M; Hirakawa S; Hanakawa Y; Hashimoto K
J Dermatol Sci; 2008 Apr; 50(1):53-60. PubMed ID: 18077140
[TBL] [Abstract][Full Text] [Related]
15. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
[TBL] [Abstract][Full Text] [Related]
16. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
Ratnam AV; Bikle DD; Su MJ; Pillai S
J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation.
Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K
J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749
[TBL] [Abstract][Full Text] [Related]
18. Intracellular free calcium and growth changes in single human keratinocytes in response to vitamin D and five 20-epi-analogues.
Jones KT; Sharpe GR
Arch Dermatol Res; 1994; 286(2):123-9. PubMed ID: 8154925
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium.
Su MJ; Bikle DD; Mancianti ML; Pillai S
J Biol Chem; 1994 May; 269(20):14723-9. PubMed ID: 7910167
[TBL] [Abstract][Full Text] [Related]
20. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
Wilhelm F; Mayer E; Norman AW
Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
